Stay Ahead with Real-Time Controlled Substance Monitoring
A controlled substance is generally a drug or chemical that a government regulates to set limitations on manufacturing, possession, or use. This may include illegal drugs and prescription medications. In the U.S., the Drug Enforcement Administration is responsible for suppressing illegal drug use and distribution by enforcing the Controlled Substances Act. Substances are classified according to schedules and consist primarily of potentially psychoactive substances. Controlled substances do not include many prescription items such as antibiotics. Other agencies, such as the Department of Health and Human Services, the Department of Transportation, and the Department of Homeland Security may issue regulations and notices related to controlled substances.
Document Statistics
Documents by Year
Documents by Type
Monitoring the Federal Register for updates on controlled substances is crucial for professionals navigating the complex landscape of drug regulation in the United States. From healthcare providers and legal advisors to state agency officials and public policy analysts, keeping abreast of the latest policy changes can have significant implications for strategic planning and risk management.
Understanding Controlled Substances
Controlled substances include drugs or chemicals regulated under government legislation due to their potential for abuse, which can lead to physical and psychological dependence. In the U.S., these substances are primarily regulated by the Drug Enforcement Administration (DEA), which enforces the Controlled Substances Act. Drugs are classified into different schedules based on their potential for abuse, accepted medical use, and the risk of dependency.
Why Monitoring Matters
-
Healthcare Providers and Pharmacists: Understanding changes in controlled substance regulations is crucial for compliance and ensuring safe prescribing practices. New regulations can affect prescribing guidelines and the availability of certain medications.
-
Legal Advisors and Law Enforcement: These professionals need to stay updated on legal changes to advise clients effectively or enforce new laws. Shifts in scheduling or new legislative measures can impact legal strategies and enforcement priorities.
-
Public Policy Analysts and State Agencies: Monitoring changes helps anticipate shifts in public health policy and funding opportunities. It allows for strategic planning and the development of programs addressing drug abuse and addiction.
-
Pharmaceutical Industry and Researchers: Keeping track of regulatory updates is vital for compliance and understanding market dynamics. New regulations can impact drug development and distribution channels.
-
Educators and Nonprofit Directors: Organizations focused on public health education and drug abuse prevention can benefit from knowing about regulatory changes to update their programs and advocacy efforts accordingly.
Recent Trends and Regulatory Impacts
Recent trends indicate an increasing focus on the opioid crisis and the regulation of synthetic drugs. Changes in schedules or new legislation regarding these substances can significantly impact various sectors, from healthcare policy to law enforcement approaches. For example, recent adjustments in how opioid prescriptions are managed have led to a broader discussion on pain management and addiction treatment.
The Benefits of AI-Powered Monitoring
The challenge for many professionals is not only staying updated but filtering through vast amounts of information for what truly matters to their field. That's where AI-powered monitoring services like FedMonitor come in.
- Customized Alerts: Receive updates about rules, notices, and regulatory changes that impact your industry directly to your inbox, phone, or even preferred collaboration tools like Slack or Microsoft Teams.
- Efficient Filtering: Our tools sift through the noise to highlight the documents and changes that are most relevant to your specific needs, speeding up the process of understanding compliance impacts.
- Real-Time Updates: Never miss a crucial update again with notifications that alert you as changes happen, allowing timely strategic adjustments.
Embrace the power of technology to stay compliant, mitigate risks, and make informed decisions. Explore how FedMonitor can support your professional needs by visiting our FAQ, or get started today by signing up for our tailored monitoring services here. For any questions, feel free to contact us. Let us help you navigate the complexities of controlled substance regulations with ease and confidence.
Search Details
- Description: A controlled substance is generally a drug or chemical that a government regulates to set limitations on manufacturing, possession, or use. This may include illegal drugs and prescription medications. In the U.S., the Drug Enforcement Administration is responsible for suppressing illegal drug use and distribution by enforcing the Controlled Substances Act. Substances are classified according to schedules and consist primarily of potentially psychoactive substances. Controlled substances do not include many prescription items such as antibiotics. Other agencies, such as the Department of Health and Human Services, the Department of Transportation, and the Department of Homeland Security may issue regulations and notices related to controlled substances.
Related Agencies
Latest Documents
| Title | Type | Published |
|---|---|---|
|
Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
|
Notice | Mar 17, 2025 |
|
Sterling Pharma USA LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
|
Notice | Mar 17, 2025 |
|
Meridian Medical Technologies, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
|
Notice | Mar 13, 2025 |
|
Patheon Pharmaceuticals Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
|
Notice | Mar 13, 2025 |
|
The Food and Drug Administration (FDA) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring Harpreet Singh for a period of 10 years from importing or offering for import any drug into the United States. FDA bases th...
|
Notice | Mar 13, 2025 |
|
Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
|
Notice | Mar 13, 2025 |
|
Sigma Aldrich Research Biochemicals Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
|
Notice | Mar 13, 2025 |
|
Stepan Company has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
|
Notice | Mar 10, 2025 |
|
LTS Therapy Systems, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
|
Notice | Mar 07, 2025 |
|
Aphena Pharma Solutions MD, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
|
Notice | Mar 06, 2025 |
|
Indivior Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
|
Notice | Mar 06, 2025 |
|
Groff Hemplex LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
|
Notice | Feb 27, 2025 |
|
Sharp Clinical Services, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
|
Notice | Feb 26, 2025 |
|
S&B Pharma LLC DBA Norac Pharma has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
|
Notice | Feb 26, 2025 |
|
Catalent Pharma Solutions, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
|
Notice | Feb 26, 2025 |
| Notice | Feb 21, 2025 | |
|
In the January 17, 2025, issue of the Federal Register, the Drug Enforcement Administration and the Department of Health and Human Services published two final rules related to the practice of telemedicine, titled "Expansion of Buprenorphine Treatmen...
|
Rule | Feb 19, 2025 |
|
Janssen Pharmaceuticals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
|
Notice | Feb 18, 2025 |
|
Scottsdale Research Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
|
Notice | Feb 18, 2025 |
|
Lonza Tampa, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
|
Notice | Feb 18, 2025 |